{"id":"W3096720517","doi":"10.1080/21645515.2020.1829899","title":"A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults","year":2020,"lang":"en","type":"article","venue":"Human Vaccines & Immunotherapeutics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"ca_institutions":"Micropharma (Canada)","funders":"Merck Sharp and Dohme","keywords":"Immunogenicity; Medicine; Tolerability; Placebo; Immunology; Adverse effect; Neutralizing antibody; Antibody titer; Randomized controlled trial; Immune system; Placebo-controlled study; Antibody; Titer; Internal medicine; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002126287,0.001492214,0.002825699,0.0003827027,0.0005353356,0.0005964484,0.0008417905,0.001641472,0.003931357],"category_scores_gemma":[0.00221199,0.0007175659,0.000891356,0.00031921,0.001154193,0.0008374458,0.0002955094,0.001838272,0.0005861134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004518175,"about_ca_system_score_gemma":0.00154866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005531439,"about_ca_topic_score_gemma":0.001088797,"domain_scores_codex":[0.9991674,0.0003947282,0.00005810509,0.0001879568,0.00008540415,0.0001063301],"domain_scores_gemma":[0.9985911,0.0004394764,0.0003867219,0.0001044028,0.0001441788,0.0003340393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9693764,0.01366613,0.000492663,0.0004599994,0.0003323779,0.00003531564,0.00005634834,0.000145742,0.007803666,0.00007447499,0.000313564,0.007243446],"study_design_scores_gemma":[0.7878457,0.2091942,0.001302803,0.00001676718,0.0002235524,0.00002003816,0.0000173549,0.0001814834,0.0007245228,0.00006666003,0.0003980113,0.000008925718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827892,0.002121965,0.000986374,0.0002834818,0.0004605521,0.01174914,0.0006122118,0.00008098956,0.0009160273],"genre_scores_gemma":[0.9672469,0.00259921,0.004015702,0.001378163,0.000698383,0.01972927,0.0008640083,0.00002974964,0.003438596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003931357,"threshold_uncertainty_score":0.01315165,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03899864370948746,"score_gpt":0.3797620391137306,"score_spread":0.3407633954042432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}